Search Results - Dahkil, Shaker

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)

    Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezoli... by Hatem, Soliman, Hargis, Jeffrey, Elias, Anthony, Lee, Arielle, Swart, Rachel, Dahkil, Shaker, Drakaki, Alexandra, Phan, Vu, Kass, Frederic, Cobleigh, Melody, Babu, Sanil, Tkaczuk, Katherine, O'Connell, Brenda, Roberts, Jennifer, Zizlsperger, Nora, Hamilton, Erika

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: